Today's Other Voices
More Other Voices
Six hedge fund managers can make their case at ABN AMRO’s Investor Forum [more]
Benedicte Gravrand, Opalesque Geneva for New Managers: ABN AMRO Clearing will host the 4th Amsterdam Investor Forum on 11th February 2015. The e
CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC [more]
Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its
Former employees of Blackrock, Macquarie and Millennium to open Hong Kong hedge fund [more]
Komfie Manalo, Opalesque Asia: Three former employees of BlackRock, Macquarie Group and Millennium Capital Management have joined hands to launch a Hong Kong-based hedge fund that will bet on trading opportunities in at least 13 Asian stock markets using computer models.
In a report, the
For hedge funds, 2014 is the year of man vs. machine [more]
Komfie Manalo, Opalesque Asia: The year 2014 is proving to be the year of man vs. machine for the hedge
fund industry, according to industry insiders.
Hong Kong-Shanghai stock link fails to live up to expectation so far [more]
Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the
bulk of activities coming from short-term speculative investors.
Opalesque Roundup: Hong Kong hedge fund exploits China credit opportunities: hedge fund news, week 52 [more]
In the week ending 19 December, 2014, reports on the latest Opalesque Hong Kong Roundtable described the opportunities Chinese SMEs provide for Hong Kong credi
Access Alternative Market Briefing
04. Dec. 2014 |
Other Voices: The evolving role of portfolio management, key trends and technology solutions for alternatives [more]
This article was authored by AlternativeSoft, a provider in asset selection, portfolio construction and fund reporting software based in the UK and Switzerland, and Global Perspectiv
03. Dec. 2014 |
Other Voices: Want to get a piece of the Swiss pension funds’ assets? [more]
This article was authored by Gabriel Kurland, managing director at Montfort Funds, a FINMA licensed representative for foreign funds in Switzerland.
Want to get your piece of the € 571 billion Swiss pension funds’ assets? Sho
02. Dec. 2014 |
Other Voices: What Will happen to the Hedge Fund Industry if we Experience a 2008 Type Market Decline? [more]
Donald A. Steinbrugge, CFA – Managing Partner, Agecroft Partners
With interest rates and credit spreads near historic lows and equity valuation above historical averages, many people are concerned that the Federal Reserve, by artificially keeping rates low, has created a 2007 type asset bubble i
27. Nov. 2014 |
Other Voices: Time diversification is a myth [more]
Research report by Alexander Ineichen of Ineichen Research & Management and Virtus Investment Partners. You can read the full report here.
Alternative investments are still not full
20. Nov. 2014 |
Other Voices: The key to transforming the fund manager/prime broker relationship [more]
This paper was authored by Sudhanshu Bahadur, Valcony Sun, and Vishal Bakshi of Sapient Global Markets. You can down
14. Nov. 2014 |
Other Voices: Hedge fund tales - or what is wrong with merger arbitrage [more]
This article was authored by Alex Gavrish, founder and CEO of Etalon Investment Research, and author of "Wall Street Back To Basics."
Hedge funds lose after Shire plc deal is cancelled
On October 20th, 2014, AbbVi
13. Nov. 2014 |
Other Voices: Five things every fund manager should know about tax planning [more]
This article was authored by William M. Funk, Principal of the Law Office of William M. Funk, New York.
As hedge fund or other alternative investment managers know, in any offering document, the tax considerations are placed near
12. Nov. 2014 |
Other Voices: Ten commandments for pitch book salvation [more]
By: Meredith Jones, Alternative Investment Research.
Last month I launched a blog series on capital raising with a diatribe about why money managers actually need a pitch book. I got several emails afterwards asking if I had any advice about what should go in an effective pitch book. Do I have
- Top Forwarded
- Top Tracked
- Top Searched
- Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]
Big hedge funds win again on PetSmart, Riverbed
From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a
- Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]
Hedge fund manager who remembers 1998 rout says prepare for pain
From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s
- Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]
Hedge funds get boost from healthcare in 2014
From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec
- North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]
From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected
- Investing - Soros buys a highly speculative biotech in the third quarter[more]
From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for